Antidiabetic properties of dietary phenolic compounds: Inhibition effects on α-amylase, aldose reductase, and α-glycosidase
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Durmaz, Lokman | |
| dc.contributor.author | Taslimi, Parham | |
| dc.contributor.author | Gülçin, İlhami | |
| dc.contributor.author | Taslimi, Parham | |
| dc.date.accessioned | 2025-10-18T13:24:27Z | |
| dc.date.created | 2019 | |
| dc.date.issued | 2019 | |
| dc.department | Fakülteler, Fen Fakültesi, Biyoteknoloji Bölümü | |
| dc.description.abstract | Aldose reductase (AR), alpha-amylase, and alpha-glycosidase are vital enzymes to prevent diabetic complications. Here, AR was purified from sheep kidney using elementary methods with 111.11-purification fold and with 0.85% purification yield. The interactions between some phenolic compounds and the AR, alpha-glycosidase, and alpha-amylase enzyme were determined. It was found that phenolic compounds exhibit potential inhibitor properties for these enzymes. For alpha-amylase, studied phenolic compounds showed IC50 values in the range of 601.56-2,067.78 nM. For alpha-glycosidase, K-i values were found in the range of 169.25 +/- 27.22-572.88 +/- 106.76 nM. For AR, K-i values in the range of 8.48 +/- 0.56-43.26 +/- 7.63 mu M. However, genistein showed the best inhibition effect toward AR and alpha-glycosidase, but delphinidin chloride exhibited the best inhibition effect against alpha-amylase enzyme. We determined that all compounds showed noncompetitive inhibition effect against AR and alpha-glycosidase. Also, studied phenolic compounds may be useful in the prevention or treatment of diabetic complications. | |
| dc.identifier.doi | 10.1002/bab.1781 | |
| dc.identifier.endpage | 786 | |
| dc.identifier.issn | 0885-4513 | |
| dc.identifier.issn | 1470-8744 | |
| dc.identifier.issue | 5 | |
| dc.identifier.orcid | Gulcin, ilhami/0000-0001-5993-1668 | |
| dc.identifier.orcid | Taslimi, Parham/0000-0002-3171-0633 | |
| dc.identifier.orcid | Demir, Yeliz/0000-0003-3216-1098 | |
| dc.identifier.pmid | 31135076 | |
| dc.identifier.scopus | 2-s2.0-85070684569 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 781 | |
| dc.identifier.uri | https://doi.org/10.1002/bab.1781 | |
| dc.identifier.uri | https://hdl.handle.net/11772/22935 | |
| dc.identifier.volume | 66 | |
| dc.identifier.wos | WOS:000480361600001 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | Biotechnology and Applied Biochemistry | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | WoS_20251016 | |
| dc.subject | Aldose Reductase | |
| dc.subject | Phenolic Compounds | |
| dc.subject | Alpha-Glycosidase | |
| dc.subject | Alpha-Amylase | |
| dc.title | Antidiabetic properties of dietary phenolic compounds: Inhibition effects on α-amylase, aldose reductase, and α-glycosidase | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | dadfa319-65b8-4543-92b4-bea49e0139e9 | |
| relation.isAuthorOfPublication.latestForDiscovery | dadfa319-65b8-4543-92b4-bea49e0139e9 |










